aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Amplified Sciences is a life science diagnostics firm specializing in early disease detection. The company focuses on accurately identifying and pre-empting the risks of debilitating diseases through advanced diagnostic technologies. Their mission is to improve patient outcomes by providing timely and precise diagnostic solutions.
Amplified Sciences has made significant strides in the field of disease detection, contributing to earlier and more accurate diagnoses. Their innovative approach has garnered attention and support from the medical community and investors, positioning them as a key player in the diagnostics market.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Diagnostics, Disease Detection
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was Amplified Sciences founded?
Amplified Sciences was founded in 2016.
Where is Amplified Sciences’s headquarters located?
Amplified Sciences’s headquarters is located in West Lafayette, IN, US.
When was Amplified Sciences’s last funding round?
Amplified Sciences’s most recent funding round was for $400k (USD) in July 2023.
How many employees does Amplified Sciences have?
Amplified Sciences has 13 employees as of Feb 5, 2024.
How much has Amplified Sciences raised to-date?
As of July 05, 2023, Amplified Sciences has raised a total of $4.7M (USD) since Jul 12, 2023.
Add Comparison
Total Raised to Date
$4.7M
USD
Last Update Jul 12, 2023
Last Deal Details
$400k
USD
Jul 12, 2023
Grant
Total Employees Over Time
13
As of Feb 2024
Amplified Sciences Address
3000 Kent Ave
West Lafayette,
Indiana
47906
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts